Abstract
Background
Surgeons are increasingly faced with the challenge of caring for obese patients. Advanced laparoscopic procedures have been shown to be safe in women with high BMI, but conversion rates remain high. Because robotics holds many potential advantages over traditional laparoscopic surgery, we sought to evaluate the outcome of robotic-assisted gynecologic surgery in obese patients.
Methods
A retrospective chart review of obese female patients undergoing robotic gynecologic surgery between January 2008 and August 2010 was done. Patients were divided into three groups based on BMI (group I, BMI 30–34.9 kg/m2; group II, BMI 35–39.9 kg/m2; and group III, BMI >40 kg/m2). Patients were assessed for baseline characteristics, comorbid conditions, and surgical outcomes and complications.
Results
A total of 128 obese patients were identified with 43 in group I, 30 in group II, and 55 in group III. There was an increased prevalence of diabetes and asthma in group III and younger age in group I. Of the 128, 117 (91 %) underwent hysterectomy and/or staging with the majority of patients having surgery for either endometrial cancer or fibroids. Conversion to laparotomy was more common in groups 2 and 3 with a positive correlation between increasing BMI and conversion. There was no difference in complications between the groups and only 1 major postoperative complication in the entire cohort.
Conclusions
Robotic-assisted gynecologic surgery can be safely performed in severely morbidly obese patients. Although conversion rates are higher with increasing obesity, a majority of procedures can still be completed minimally invasively.
Similar content being viewed by others
References
Ogden CL, Carroll MD, Kit BK, Felgal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311:806–14.
Health implications of obesity. National Institutes of Health Consensus Development Conference Statement. Ann Intern Med. 1985;103:1073–7.
Pi-Sunyer FX. Health implications of obesity. Am J Clin Nutr. 1991;53 suppl:1595S–603S.
Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 1990;322:882–9.
Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968–77.
Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chronic Dis. 1979;32: 563–76.
Overweight and obesity. The Center for Disease Control and Prevention. http://www.cdc.gov/obesity/data/trends.html.
Pitkin RM. Abdominal hysterectomy in obese women. Surg Gynecol Obstet. 1976;142:532–6.
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity and mortality from cancer in prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–38.
Bamgbde OA, Rutter TW, Naflu OO, Dorie P. Postop complications in obese and non-obese patients. World J Surg. 2007;31:556–60.
Gomel V, Taylor PJ. Indications and contraindications of diagnostic laparoscopy. In: Gomel V, Taylor PJ, eds. Diagnostic and Operative Gynecologic Laparoscopy. 1st ed. St. Louis: Mosby-Year Book, 1995:68–70.
Holloway RW, Patel SD, Ahmed S. Robotic surgery in gynecology. Scand J Surg. 2009;98:96–109.
Eltabbakh GH, Piver MS, Hempling RE, Recio FO. Laparoscopic surgery in obese women. Obstet Gynecol. 1999;94:704–8.
O’Hanlan KA, Lopez L, Dibble SL, Garnier AC, Huang GS, Leuchtenberger M. Total laparoscopic hysterectomy: Body mass index and outcomes. Obstet Gynecol. 2003;102:1384–92.
Lambaudie E, Houvenaeghel G, Walz J, Bannier M, Buttarelli M, Gurriet B, De Laparrent T, Blanche JL. Robot-assisted laparoscopy in gynecologic oncology. Surg Endosc. 2008;22:2743–7.
Gehrig PA, Cantrell LA, Shafer A, Abaid LN, Mendivil A, Boggess JF. What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese women? Gynecol Oncol. 2008;111:41–5.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.
Kaye AD, Vadivelu N, Ahuja N, Mitra S, Silasi D, Urman RD. Anesthetic considerations in robotic-assisted gynecologic surgery. Ochsner J. 2013;13:517–24.
Walker JL, Piedmonte MR, Spirtos NM, et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clinical Oncol. 2009;27:5331–6.
Kornblith AB, Huang HQ, Walker JL, Spirtos NM, Rotmensch J, Cella D. Quality of life of patients with endometrial cancer undergoing Laparoscopic International Federation of Gynecology and Obstetrics Staging Compared with Laparotomy: A Gynecologic Oncology Group Study. J Clin Oncol. 2009; 27:5337–42.
Tang KY, Gardiner SK, Gould C, et al. Robotic surgical staging for obese patients with endometrial cancer. Am J Obstet Gynecol. 2012;206:513e1–6
Subramaniam A, Him KH, Bryant SA, et al. A cohort study evaluating robotic versus laparotomy surgical outcomes of obese women with endometrial carcinoma. Gynecol Oncol. 2011;122:604–7.
Seamon LG, Fowler JM, Richardson DL, Carlson MJ, Valmadre S, Phillips GS, Cohn DE. A detailed analysis of the learning curve: robotic hysterectomy and pelvic-aortic lymphadenectomy for endometrial cancer. Gynecol Oncol. 2009;114:162–7.
DISCLOSURES
The authors report no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cosin, J.A., Brett Sutherland, M.A., Westgate, C.T. et al. Complications of Robotic Gynecologic Surgery in the Severely Morbidly Obese. Ann Surg Oncol 23, 4035–4041 (2016). https://doi.org/10.1245/s10434-016-5340-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-016-5340-y